Recreo Pharmaceuticals
Recreo Pharmaceuticals is dedicated to overcoming antibiotic resistance through innovative drug development. Their mission is to control and conquer bacterial antibiotic resistance, enabling previously effective antibiotics to be used again and deploying first-in-class antimicrobial compounds. They focus on developing resistance-modifying agents and broad-spectrum antibiotics inspired by natural compounds, aiming to address the global health crisis of antimicrobial resistance.
Industries
Nr. of Employees
small (1-50)
Recreo Pharmaceuticals
Products
Resistance-modifying agent (RMA) program
A development program focused on small-molecule compounds that reverse bacterial resistance to β-lactam antibiotics, intended to restore the clinical utility of β-lactams against resistant bacteria such as MRSA.
First-in-class broad-spectrum antibiotic program
A program to develop novel synthetic antimicrobial compounds with potent activity against both Gram-negative and Gram-positive bacteria, derived from chemically modified natural-product-inspired scaffolds.
First-in-Class Broad Spectrum Antimicrobials
Novel compounds developed through chemical modification of synthetic scaffolds inspired by natural indole-alkaloids, effective against both Gram-negative and Gram-positive bacteria.
Resistance Modifying Agents (RMAs)
A set of compounds developed to reverse bacterial resistance to β-lactam antibiotics, restoring their potency against MRSA.
Resistance-modifying agent (RMA) program
A development program focused on small-molecule compounds that reverse bacterial resistance to β-lactam antibiotics, intended to restore the clinical utility of β-lactams against resistant bacteria such as MRSA.
First-in-class broad-spectrum antibiotic program
A program to develop novel synthetic antimicrobial compounds with potent activity against both Gram-negative and Gram-positive bacteria, derived from chemically modified natural-product-inspired scaffolds.
First-in-Class Broad Spectrum Antimicrobials
Novel compounds developed through chemical modification of synthetic scaffolds inspired by natural indole-alkaloids, effective against both Gram-negative and Gram-positive bacteria.
Resistance Modifying Agents (RMAs)
A set of compounds developed to reverse bacterial resistance to β-lactam antibiotics, restoring their potency against MRSA.
Expertise Areas
- Antibiotic discovery and development
- Antimicrobial resistance solutions
- Medicinal chemistry
- Natural-product-inspired synthetic chemistry
Key Technologies
- Medicinal chemistry
- Natural product-inspired synthetic scaffolds
- Resistance-modifying agents (RMAs)
- Broad-spectrum antibiotic discovery